Induction Chemotherapy With Afatinib, Ribavirin, and Weekly Carboplatin/Paclitaxel for Stage IVA/IVB HPV Associated Oropharynx Squamous Cell Cancer (OPSCC)

NCT01721525 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer
Squamous Cell Cancer

Interventions

DRUG: Afatinib, Ribavirin, and weekly carboplatin/paclitaxel

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]